Cefpen S 125mg/62.5mg Injection
Marketer
Morepen Laboratories Ltd
Salt Composition
Ceftriaxone (125mg) + Sulbactam (62.5mg)
Overview Cefpen S 125mg/62.5mg Injection
Combiflox, a 125mg/62.5mg injectable antibiotic, combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a medical professional; strict adherence to the prescribed dosage and schedule is crucial for efficacy. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require prompt emergency care. Prior to commencing treatment, disclose all current medications and health conditions to your physician. Consult your doctor if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Sufficient rest, a nutritious diet, and ample hydration are recommended for optimal recovery. Your doctor may order tests to monitor treatment response.
Primary Ingredients of Cefpen S 125mg/62.5mg Injection
No text was provided to rewrite.
Uses of Cefpen S 125mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Cefpen S 125mg/62.5mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Cefpen S 125mg/62.5mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefpen S 125mg/62.5mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cefpen S 125mg/62.5mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefpen S 125mg/62.5mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, safeguards Ceftriaxone's effectiveness by neutralizing enzymes that bacteria use to defend against it.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Cefpen S 125mg/62.5mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Cefpen S 125mg/62.5mg injections are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Cefpen S 125mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefpen S 125mg/62.5mg Injection can induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefpen S 125mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The use of Cefpen S 125mg/62.5mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Cefpen S 125mg/62.5mg Injection is not advised for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Cefpen S 125mg/62.5mg Injection :
Omit a Cefpen S 125mg/62.5mg Injection dose? Seek medical advice immediately.
Facts to Know About Cefpen S 125mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Anti-infective agents |
3,018 People bought this recently